**Core Concept:** Heparin is an anticoagulant drug that works by inhibiting the activation of factor X (factor Xa) in the extrinsic coagulation cascade. It prevents the formation of fibrin clot and thus reduces blood coagulation. Drugs that act on the same coagulation cascade can have increased effect when given in combination with heparin.

**Why the Correct Answer is Right:** When given together, heparin potentiates the effect of drugs that target the coagulation cascade. In this case, option C (enoxaparin) is an anticoagulant that shares the same target (factor Xa inhibition) with heparin. Combining them increases the inhibition of factor Xa, leading to enhanced anticoagulation effect.

**Why Each Wrong Option is Incorrect:**

A. Warfarin (option A) is an oral anticoagulant that targets vitamin K-dependent clotting factors (II, VII, IX, X, XI, and XII). When given with heparin, the effect is generally additive, not potentiated, as they act on different pathways (vitamin K pathway vs. factor Xa inhibition).

B. Argatroban (option B) is a direct thrombin inhibitor that inhibits thrombin (factor IIa) and has a similar mechanism to warfarin. Similar to warfarin, their combination typically results in an additive effect.

D. Heparin-induced thrombocytopenia (HIT) is a rare adverse reaction to heparin, characterized by thrombocytopenia and increased thrombosis risk. In some cases, HIT may occur due to the formation of antibodies against heparin-platelet factor 4 complex. However, this explanation does not directly address the correct answer.

**Clinical Pearl:** When selecting anticoagulant therapy, consider the pharmacological interactions to minimize potential adverse events and optimize treatment outcomes. Always monitor patients on dual anticoagulation therapy (heparin + another anticoagulant) for signs of heparin-induced thrombocytopenia (HIT).

---

**Question:** Which of the following drug can have increased effect when given with heparin?

**Correct Answer:** Enoxaparin (option C) is a low molecular weight heparin that shares the same target (factor Xa inhibition) as heparin. Their combination results in potentiated anticoagulation effect due to the additive inhibition of clotting factors.

**Why Each Wrong Option is Incorrect:**

A. Warfarin (option A) is a vitamin K antagonist that inhibits vitamin K-dependent clotting factors (II, VII, IX, X, XI, and XII), and its combination with heparin does not generally enhance the anticoagulant effect.

B. Argatroban (option B) is a direct thrombin inhibitor that inhibits thrombin (factor IIa) and does not share the same target as heparin (factor Xa inhibition). Combining these drugs does not result in enhanced anticoagulation effect.

C. Heparin-induced thrombocytopenia (